mlsanityData to 7 Oct 2026

Leveraging Biokinetic Knowledge Priors for Data-Scarce Bioprocess Modeling

arXiv 2607.20539 ↗First posted 10 Jul 2026cs.LG cs.AIcited by 0

Not on the map. Why?

Abstract (arXiv)

While deep learning has accelerated drug discovery, its impact on biomanufacturing has been considerably more limited. The reason is data scarcity. Bioreactor experiments are high-cost, take days to weeks, and are rarely shared in public form, leaving each research work with only a handful of experiments. The domain itself, however, is rich in prior knowledge. Biokinetic ordinary differential equation (ODE) models have described microbial growth for decades, yet how to inject this knowledge into a neural network has not been studied systematically. We present the first systematic study of how to inject this ODE knowledge into a neural network, comparing a data-level prior that pre-trains a generic decoder on simulated ODE curves against an architecture-level prior that embeds the ODE inside the decoder. Both consistently outperform no-prior baselines across 11 datasets and 7 microbial species. Our central finding is that the two are substitutable. A generic decoder pre-trained on simulation matches a fully bio-structured decoder trained on real data. Simulation pre-training therefore offers a simple, data-efficient recipe for deep learning under bioprocess data scarcity.

Key facts. No citing papers in the map yet (data through 7 Oct 2026). Builds on 7 of its 49 references that are in the map. First posted on arXiv 10 Jul 2026.

Builds on

7 of 49 references.

References · 7

  1. 2018Neural Ordinary Differential Equationscited by 3,733
  2. 2022TabPFN: A Transformer That Solves Small Tabular Classification Problems in a Secondcited by 643
  3. 2020Drug discovery with explainable artificial intelligencecited by 118
  4. 2024How to Build the Virtual Cell with Artificial Intelligence: Priorities and Opportunitiescited by 50
  5. 2019Reinforcement Learning for Batch Bioprocess Optimizationcited by 24
  6. 2022Machine learning in bioprocess development: From promise to practicecited by 4
  7. 2023Applications of Machine Learning in Biopharmaceutical Process Development and Manufacturing: Current Trends, Challenges, and Opportunitiescited by 2

Built on by

Not cited yet.